AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04576364 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium sulfate for 24 hour
Description: drug used to prevent convulsions in patients having preeclampsia with severe features
Study NCT04531566 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral Feed
Description: Infant will be seen by occupational therapist (OT) twice a week and assessed for oral cues. If infant shows oral cues then the occupational therapist will proceed with feeding strategies. Oral feeding strategies include pacifier dips, open nipple trials with syringe controlled bolus size (1-4mls) and po trials up to 10mls.
Study NCT04531566 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Infants will not start oral feeds until on HFNC 2 Litres or less. Oral feeds will be started on the discretion of the physician.
Study NCT03909178 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hip Arthroscopy Surgery with Acetabular Labral Repair (SPT group)
Description: Patients randomized to the SPT group provided consent for arthroscopic acetabular labral repair with femoroacetabular osteoplasty. As previously described in various technique publications from our group, the senior surgeon's (S.D.M.) hip arthroscopy technique includes intra-articular fluid distension for initial portal placement, puncture capsulotomy, autograft capsular augmentation if insufficient or degenerative labral tissue is encountered, intermittent traction, sparing use of electrocautery, and preservation of the chrondrolabral junction. All SPT patients underwent a standardized postoperative physical therapy protocol developed jointly by the senior author (a sports medicine fellowship-trained orthopaedic surgeon) and the physical therapists. Patients were kept weightbearing as tolerated on crutches for 6 weeks to maintain a level pelvis without lurching when walking and were instructed to avoid impact loading exercises for 6 months.
Study NCT03909178 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Physical Therapy Focused on the Hip and Hemi-pelvis (PT group)
Description: PTA patients were assigned a standardized, 24-week course of supervised, core-based PT. This course was designed in concert with physical therapists within our institution to help address symptoms of labral tear in patients older than 40 who had mild to moderate OA. Weeks 1 and 2 focused on normalizing gait, and weeks 3 through 24 focused on optimizing range of motion (ROM) while slowly integrating strength training. Unlike the prerandomization PT protocol, the PTA protocol was predominantly physical therapist-supervised (at least 1 in-person visit per week).
Study NCT02355613 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiosurgery with Gamma Knife Perfexion
Description: Gamma Knife Radiosurgery is a very precise form of therapeutic radiology. Even though it is called surgery, a Gamma Knife procedure does not involve actual surgery but it uses 192 isocentric beams of highly-focused gamma rays (60-Co) to treat small to medium size lesions. Minimum beam size is 4 mm. This procedure is frame based.
Study NCT02355613 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Linac-based Radiosurgery with EDGE
Description: EDGE linear accelerator from Varian (Varian, Palo Alto, USA) is a C-arm machine specifically developed for radiosurgery frameless treatment. The characteristics of this linac are a high level of precision and the possibility to include multiple positioning systems for stereotactical treatments, among which Cone Beam CT (CBCT), the Optical Surface Monitoring System (OSMS), and Calypso.
Study NCT01861457 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nozin® Nasal Sanitizer®
Description: The treatment agent tested was the alcohol and natural oil preparation that comprises the commercially available over-the-counter (OTC) product, NOZIN® Nasal Sanitizer® antiseptic, by Global Life Technologies Corp, with the addition of benzalkonium chloride (0.13%), as described for the patented and safety-tested formulation.
Study NCT01861457 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo preparation, utilized to account for the potential mechanical effects of the application process, was phosphate buffered saline (PBS).
Study NCT01786330 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Procare abdominal binder
Study NCT01786330 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Study NCT03039439 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Previously collected tumor tissue and blood samples
Study NCT03039439 — intervention group
Intervention type: OTHER
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT03201965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: Participants will receive 300 mg/m\^2 of cyclophosphamide as an oral or IV dose.
Study NCT03201965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bortezomib
Description: Participants will receive 1.3 mg/m\^2 of bortezomib as an subcutaneous (SC) injection.
Study NCT03201965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone, 40 mg
Description: Participants of CyBorD alone arm will receive 40 mg dexamethasone orally or IV dose. Participants of CyBorD plus daratumumab arm will receive dexamethasone 20 mg orally or IV dose as premedication and 20 mg on the day after daratumumab dosing to make a total of 40 mg.
Study NCT03201965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Participants will receive 1800 mg of daratumumab subcutaneously.
Study NCT05924399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Affect Labeling Training
Description: (1) Participants will view combat-relevant images and then label the image or how they feel while viewing the image. (2) Participants will view facial expressions and then label the image. (3) Participants will view negative combat- irrelevant images (such as snakes or spiders) and then label the image or how they feel while viewing the image. (4) Participants will complete Go-NoGo trials similar to the fMRI Go-NoGo task described above. Participants will receive all four types of inhibitory training.
Study NCT00524030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pregabalin 600 mg/day
Description: pregabalin 600 mg/day (300mg BID), duration is 20 weeks.
Study NCT00524030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pregabalin 150 mg/day
Description: pregabalin 150 mg/day (75mg BID), duration is 20 weeks.
Study NCT02178644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemo with concomitant Capecitabine and KD018
Description: Patients will receive a course of chemo-radiation with concomitant Capecitabine and KD018, and to compare this to the toxicity seen in patients treated with Capecitabine and radiation therapy alone, in patients with T3-T4 and N0-N2, M0 rectal cancer.
Study NCT02914132 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Seraph 100 Filter
Description: Treatment of renal replacement therapy patients with bacteremia.
Study NCT04254484 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SIESTA Rehab Education
Description: Staff nurses will be trained on how to improve sleep in stroke patients in the acute rehabilitation setting.
Study NCT04254484 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ApneaLink
Description: Stroke patients on the SIESTA Rehab unit will be screened for sleep disordered breathing using ApneaLink monitors. Results will be interpreted by a sleep specialist who will then advise the clinical team at SRALab.
Study NCT01315730 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tactile Stimulation
Description: See Arms
Study NCT06763978 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcatheter PDA closure
Description: Transcatheter PDA closure
Study NCT03477175 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E7080
Description: Oral Administration.
Study NCT03477175 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Comparator Drug
Description: Per parent study.
Study NCT03477175 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Comparator Drug: Sorafenib
Description: Per parent study.
Study NCT02929355 — intervention group
Intervention type: OTHER
Intervention: carotid assesment by duplex ultrasonography
Study NCT02107794 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Decision Aid
Description: Paper based decision aid will be utilized to facilitate treatment option conversation between clinician and patient.
Study NCT02335008 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sucralose
Description: 2 packets per 12 fl oz
Study NCT02335008 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sucrose
Description: equisweet to sucralose
Study NCT00175344 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scar massage.
Description: To objectively evaluate the effects of scar massage, those who agree to participate will be randomly assigned to one of two groups. One group will be taught to perform self-massage of the scars as soon as the scars have adequately healed. The massage should be done about 10 minutes each day for a total of 6 months. The other group will not be taught self-massage and will be asked to not massage their breast scars.
Study NCT04246372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Description: Treatment with oral Tofacitinib for immune mediated skin conditions in adults with Down syndrome
Study NCT01377480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Posaconazole
Description: POS 40 mg/mL oral suspension
Study NCT01261572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: degarelix
Description: periodic injection
Study NCT02119689 — intervention group
Intervention type: OTHER
Intervention: Diabetic Patients
Description: measuring CD34 cell function in relation to diabetic retinopathy status
Study NCT01377480 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo for posaconazole
Description: Placebo oral suspension
Study NCT02119689 — intervention group
Intervention type: OTHER
Intervention: Healthy Controls
Description: measuring CD34 cell function
Study NCT01377480 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for posaconazole
Description: Placebo oral suspension
Study NCT01377480 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Benznidazole
Description: BNZ 100 mg oral tablet
Study NCT01377480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benznidazole
Description: BNZ 100 mg oral tablet
Study NCT04556994 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Phase 1 Cardiac Rehabilitation
Description: Step 1:Breathing exercises, 3 sets of 10 repetitions. Active upper and lower extremity exercises, 3 sets of 10 repetitions; bed inclined at 45°.~Step 2:Active exercises as in step 1. Stay in the upright position and perform walking on the spot for three series of 1 min.~Step 3:Active exercises as in step 2. Ambulation within the inpatient wards (7 min). Transfer to an allocated chair beside the bed (at least 30 min).~Step 4:Same exercises as in step 3. Ambulation within the inpatient wards (10 min). Transfer to an allocated chair beside the bed (at least 1 h).~Step 5:Same exercises as in step 4. Ambulation within the inpatient wards (15 min). Transfer to an allocated chair beside the bed (at least 2 h).~Step 6:Active exercises from the previous day. Ambulation within the inpatient wards (20 min). Step training (3 times continuously, 20 cm standardized step).~Step 7:Exercises from the previous day. Step training (6 times continuously, 20 cm standardized step).
Study NCT04556994 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phase 1 Cardiac Rehabilitation with Lower Limb Paddling
Description: Step 1 to step 6 of Phase 1 Cardiac Rehabilitation given to the patients along with Lower limb exercise on Paddler lasting 20 min (5-min warm-up, 10 min of low-intensity exercise, and 5-min recovery), 30 rpm ( rotation per minute)
Study NCT05386667 — intervention group
Intervention type: DRUG
Intervention: Majezik %0.25 oral spray
Description: Free gingival graft was taken from the palatal mucosa of the patients in order to increase the attached gingiva.~After FGG, the patients were asked to apply this spray to the palatal mucosa 3 times a day.
Study NCT05386667 — intervention group
Intervention type: OTHER
Intervention: Aftamed oral spray
Description: Free gingival graft was taken from the palatal mucosa of the patients in order to increase the attached gingiva.~After FGG, the patients were asked to apply this spray to the palatal mucosa 3 times a day.
Study NCT05386667 — intervention group
Intervention type: OTHER
Intervention: Crystalin oral spray
Description: Free gingival graft was taken from the palatal mucosa of the patients in order to increase the attached gingiva.~After FGG, the patients were asked to apply this spray to the palatal mucosa 3 times a day.
Study NCT05386667 — intervention group
Intervention type: PROCEDURE
Intervention: Free gingival graft harvesting
Description: Free gingival graft was taken from the palatal mucosa of the patients in order to increase the attached gingiva.
Study NCT00876915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dalteparin injection
Description: Potency is described in international anti-Xa units (IU). One unit (anti-Xa) of dalteparin sodium, average molecular weight 5,000, corresponds to the activity of one unit of the 1st International Standard for Low Molecular Weight Heparin (LMWH)with respect to inhibition of coagulation Factor Xa in plasma utilizing the chromogenic peptide substrate S-2765 (N-alpha-Benzyloxycarbonyl-D-arginyl-glycyl-arginine-pNA.2HCl).
Study NCT03333915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pamiparib
Description: Pamiparib is provided as oral capsules
Study NCT01544166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadobutrol (Gadavist, BAY86-4875)
Description: Single intravenous bolus injection of gadobutrol 0.1 mmol/kg BW in term newborns to infants \<2 years of age.
Study NCT02079948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate + Folic Acid
Description: Participants in the methotrexate + folic acid condition will have a~* Blood draw at each monthly visit~* Cognitive performance testing to assess memory performance~* Physical function testing to assess walking speed and measure muscle endurance~* Pain assessment testing to assess the presence and location of daily pain~* Self-reported function and quality of life to measure disability and mobility limitations, and~* Depression assessment testing to assess participants' level of depression.
Study NCT00695786 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study NCT00695786 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Given IV
Study NCT02699502 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: matching an appropriate drug therapy to patients with osteoporotic hip fractures
Description: The process involves reviewing patients characteristics virtually and finding the right drug for them while they are still in the hospital. After matching an appropriate drug, getting it through regulatory authorities to the family physician
Study NCT02162771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Study NCT02162771 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Study NCT02629835 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: intravenous 8 mg dexamethasone and perineural 0.8 ml of saline solution
Study NCT02629835 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: intravenous 0,8 ml of saline solution and perineural 8 mg of dexamethasone
Study NCT03912493 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Game Based Virtual Reality Exercises
Description: A game-based virtual reality device named USE-IT will be added to the rehabilitation program. USE-IT is a technological rehabilitation system designed by the Department of Physiotherapy and Rehabilitation at Hacettepe University. It is a smart gaming device which has been used in patients who suffer from movement loss in their upper extremities due to various neurological and orthopedic reasons.
Study NCT03912493 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy and Rehabilitation
Description: The conventional physiotherapy and rehabilitation program includes the application of Transcutaneous Electrical Nerve Stimulation (TENS), cold pack, therapeutic ultrasound, Codman Exercises, Wand exercises, shoulder wheel exercises, finger ladder exercises, strengthening exercises with elastic band and capsule stretching.
Study NCT00979823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early SimCare Diabetes Group
Description: Residents in the early learning program group will participate in the learning cases before undergoing a knowledge and performance assessment. They will complete 18 learning cases, 4 assessment cases, knowledge survey, and a satisfaction survey.
Study NCT00979823 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Delayed SimCare Diabetes Group
Description: Residents in the delayed learning program group will receive their usual diabetes training through their residency program for 8 months before completing the knowledge and performance assessment, and then will subsequently be offered the learning program. They will receive 4 assessment cases, knowledge survey, and satisfaction survey
Study NCT03324438 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Telehealth T1D C2oYoT1-HR
Description: 1) assessment of physical and behavioral health characteristics associated with high-risk status; 2) delivery of home telehealth that incorporates: 2a) medical and behavioral health care delivered with the endocrinologist and behavioral health specialist working together with high-risk youth; 2b) personalized intervention to improve T1D adherence and T1D clinical health outcomes; 2c) personalized intervention to improve mental health comorbidities and T1D clinical health outcomes; and 3) an underused methodological approach for optimizing intervention components to be delivered at point of care.
Study NCT02162771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine
Study NCT02079948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo + Folic Acid
Description: Participants in the placebo + folic acid condition will have a~* Blood draw at each monthly visit~* Cognitive performance testing to assess memory performance~* Physical function testing to assess walking speed and measure muscle endurance~* Pain assessment testing to assess the presence and location of daily pain~* Self-reported function and quality of life to measure disability and mobility limitations, and~* Depression assessment testing to assess participants' level of depression
Study NCT02079948 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Functional MRI Experimental Tasks
Description: Participants who are randomly assigned to the fMRI scan wil receive their study drugs at the the Baseline fMRI visit. Participants who are randomly assigned to the fMRI will also attend complete their last visit at the 6 month period.
Study NCT02079948 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Functional MRI Experimental Tasks
Description: Participants who are randomly assigned to the fMRI scan wil receive their study drugs at the the Baseline fMRI visit. Participants who are randomly assigned to the fMRI will also attend complete their last visit at the 6 month period.
Study NCT02079948 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Muscle Biopsy
Description: Participants who are randomly assigned to the muscle biopsy assessment of the study will receive their study drugs at the Baseline muscle biopsy visit. Participants who are randomly assigned to the muscle biopsy portion of the study will also complete their last visit at the 6 month period.
Study NCT02079948 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Muscle Biopsy
Description: Participants who are randomly assigned to the muscle biopsy assessment of the study will receive their study drugs at the Baseline muscle biopsy visit. Participants who are randomly assigned to the muscle biopsy portion of the study will also complete their last visit at the 6 month period.
Study NCT03324438 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home Telehealth T1D C2oYoT1-HR
Description: 1) assessment of physical and behavioral health characteristics associated with high-risk status; 2) delivery of home telehealth that incorporates: 2a) medical and behavioral health care delivered with the endocrinologist and behavioral health specialist working together with high-risk youth; 2b) personalized intervention to improve T1D adherence and T1D clinical health outcomes; 2c) personalized intervention to improve mental health comorbidities and T1D clinical health outcomes; and 3) an underused methodological approach for optimizing intervention components to be delivered at point of care.
Study NCT03324438 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Behavioral Health
Description: 1) assessment of physical and behavioral health characteristics associated with high-risk status; 2) delivery of home telehealth that incorporates: 2a) medical and behavioral health care delivered with the endocrinologist and behavioral health specialist working together with high-risk youth; 2b) personalized intervention to improve T1D adherence and T1D clinical health outcomes; 2c) personalized intervention to improve mental health comorbidities and T1D clinical health outcomes; and 3) an underused methodological approach for optimizing intervention components to be delivered at point of care.